» Articles » PMID: 10890911

Association of Smads with Lymphoid Enhancer Binding Factor 1/T Cell-specific Factor Mediates Cooperative Signaling by the Transforming Growth Factor-beta and Wnt Pathways

Overview
Specialty Science
Date 2000 Jul 13
PMID 10890911
Citations 160
Authors
Affiliations
Soon will be listed here.
Abstract

The transforming growth factor-beta (TGFbeta) and Wnt/wingless pathways play pivotal roles in tissue specification during development. Activation of Smads, the effectors of TGFbeta superfamily signals, results in Smad translocation from the cytoplasm into the nucleus where they act as transcriptional comodulators to regulate target gene expression. Wnt/wingless signals are mediated by the DNA-binding HMG box transcription factors lymphoid enhancer binding factor 1/T cell-specific factor (LEF1/TCF) and their coactivator beta-catenin. Herein, we show that Smad3 physically interacts with the HMG box domain of LEF1 and that TGFbeta and Wnt pathways synergize to activate transcription of the Xenopus homeobox gene twin (Xtwn). Disruption of specific Smad and LEF1/TCF DNA-binding sites in the promoter abrogates synergistic activation of the promoter. Consistent with this observation, introduction of Smad sites into a TGFbeta-insensitive LEF1/TCF target gene confers cooperative TGFbeta and Wnt responsiveness to the promoter. Furthermore, we demonstrate that TGFbeta-dependent activation of LEF1/TCF target genes can occur in the absence of beta-catenin binding to LEF1/TCF and requires both Smad and LEF1/TCF DNA-binding sites in the Xtwn promoter. Thus, our results show that TGFbeta and Wnt signaling pathways can independently or cooperatively regulate LEF1/TCF target genes and suggest a model for how these pathways can synergistically activate target genes.

Citing Articles

Affinity-tagged SMAD1 and SMAD5 mouse lines reveal transcriptional reprogramming mechanisms during early pregnancy.

Liao Z, Tang S, Nozawa K, Shimada K, Ikawa M, Monsivais D Elife. 2024; 12.

PMID: 38536963 PMC: 10972565. DOI: 10.7554/eLife.91434.


A distinct isoform of lymphoid enhancer binding factor 1 (LEF1) epigenetically restricts EBV reactivation to maintain viral latency.

Ward B, Prasai K, Schaal D, Wang J, Scott R PLoS Pathog. 2023; 19(12):e1011873.

PMID: 38113273 PMC: 10763950. DOI: 10.1371/journal.ppat.1011873.


Targeting transforming growth factor beta signaling in metastatic osteosarcoma.

Ge R, Huang G J Bone Oncol. 2023; 43:100513.

PMID: 38021074 PMC: 10666000. DOI: 10.1016/j.jbo.2023.100513.


LEF1 isoforms regulate cellular senescence and aging.

Jia M, Sayed K, Kapetanaki M, Dion W, Rosas L, Irfan S Aging Cell. 2023; 22(12):e14024.

PMID: 37961030 PMC: 10726832. DOI: 10.1111/acel.14024.


Identification of Maleimide-Fused Carbazoles as Novel Noncanonical Bone Morphogenetic Protein Synergizers.

Riege D, Herschel S, Heintze L, Fenkl T, Wesseler F, Sievers S ACS Pharmacol Transl Sci. 2023; 6(8):1207-1220.

PMID: 37588754 PMC: 10426274. DOI: 10.1021/acsptsci.3c00103.


References
1.
Wrana J . Regulation of Smad activity. Cell. 2000; 100(2):189-92. DOI: 10.1016/s0092-8674(00)81556-1. View

2.
Roose J, Huls G, van Beest M, Moerer P, van der Horn K, Goldschmeding R . Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science. 1999; 285(5435):1923-6. DOI: 10.1126/science.285.5435.1923. View

3.
Attisano L, Wrana J . Smads as transcriptional co-modulators. Curr Opin Cell Biol. 2000; 12(2):235-43. DOI: 10.1016/s0955-0674(99)00081-2. View

4.
Abdollah S, Hoodless P, Pirone R, Attisano L, Wrana J . MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell. 1996; 87(7):1215-24. DOI: 10.1016/s0092-8674(00)81817-6. View

5.
Korinek V, Barker N, Morin P, van Wichen D, de Weger R, Kinzler K . Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science. 1997; 275(5307):1784-7. DOI: 10.1126/science.275.5307.1784. View